BackHorizon Therapeutics Plc Overview
Horizon Therapeutics Plc

Horizon Therapeutics Plc Discounted Cash Flow

DCF Analysis for HZNP.

Get informed when a big investor buys or sells

+ Follow

Fair Value

$275.01

Current Fair Value

$275.01
136.5% Upside

Undervalued by 136.5% based on the discounted cash flow analysis.

Average Upside/Downside (Comparison Companies)

Loading

Fair Value vs. Stock Price History

Loading

Upside/Downside History

Loading

Upside/Downside Comparison

Loading